Lixte Biotechnology
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,987 | -2,540 | -2,030 | -773 |
EBIT | -5,104,110 | |||
Net Income | -1,923 | -2,543 | -2,030 | -775 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,856 | -1,087 | -926 | -487 |
Cash | 3,250 | 5,106 | 2,887 | 887 |
Basic Shares | 10,889 | 48,407 | 6,171 | 2,720 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,000 | -3,569 | -5,070 | -6,303 |
EBIT | -3,602 | -5,086 | -6,312 | |
Net Income | -6,009 | -3,585 | -5,087 | -6,312 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,070 | -3,164 | -4,293 | -4,611 |
Cash | 5,106 | 1,038 | 4,203 | 5,353 |
Basic Shares | 48,407 | 2,249 | 1,915 | 158 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.17 |
2025-12-31 | -$0.33 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.29 |